American Regent Competitors and Similar CompaniesClear all

American Regent's competitors and similar companies include Nippon Chemiphar, Laboratorio Reig Jofre, Cooper and Bernofarm.

	American Regent American Regent (previously known as Luitpold Pharmaceuticals) is a company that develops, manufactures, and supplies drugs and medical devices.	Nippon Chemiphar Nippon Chemiphar is a pharmaceutical company that specializes in the development of generic drugs.	Laboratorio Reig Jofre Laboratorio Reig Jofre researches, develops, manufactures, markets, and sells medicines and nutritional supplements.	Cooper Cooper is an over-the-counter drug manufacturer and distributor.	Bernofarm Bernofarm is a manufacturer of pharmaceutical products.
Founding Date	Founding Date 1967	Founding Date 1950	Founding Date 1929	Founding Date 1907	Founding Date 1971
Type	Type Subsidiary	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare clinics drug development hospitals medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare cosmetics drug development medical devices pharma supplements	Tags Healthcare distribution medical devices pharma	Tags Healthcare drug development medical devices pharma
Locations	Locations New York, US HQ Audubon, US New Albany, US	Locations Chiyoda City, JP HQ Fukuoka, JP Osaka, JP Saitama, JP Sapporo, JP Sendai, JP	Locations Sant Joan Despí, ES HQ Bruxelles, BE Monaco, MC Warszawa, PL Oeiras, PT Singapore, SG Madrid, ES see more	Locations Melun, FR HQ Saint Fargeau Ponthierry, FR	Locations ID HQ
Employees	Employees 8762% increase	Employees 887	Employees 1,331	Employees 306	Employees 1,0971% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 34.7 m	Valuation ($) 255.9 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥32.6b (FY, 2025)	Revenue (est.) €331.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ¥22.4b (FY, 2025)	Cost of goods €137.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥10.1b (FY, 2025)	Gross profit €208.2m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ¥294m (FY, 2025)	Net income €5m (FY, 2025)	Net income N/A	Net income N/A